Facebook pixel

Our medical

advisors

Our medical advisors are external experts convened by Pseudomyxoma Survivor to get their professional advice and insights on a specific topic for which the expertise and knowledge are not available within the company. Advisors (experts in their areas) could be healthcare professionals (HCP), patients or caregivers.

Having these advisors serves several important purposes for us:

  • Providing medical expertise
    The advisors can review content and provide guidance on the latest advances in diagnosing and managing pseudomyxoma peritonei and appendix cancers. This helps ensure Pseudomyxoma Survivor is providing accurate and timely information.
  • Facilitating research collaborations
    The advisors may be able to connect us with researchers at their institutions, enabling new studies on pseudomyxoma peritonei (PMP) and appendix cancers. They can also review and advise on research grant proposals submitted to the organization.
  • Educating patients and physicians
    The advisors can give lectures and presentations to online sessions.
  • Provide grounding
    Patients and caregivers can see that Pseudomyxoma Survivor is grounded in authoritative medical knowledge and expertise.
  • Improving patient care
    Ultimately, the medical advisors help further the mission of Pseudomyxoma Survivor by advancing research, expanding access to optimal treatments, and enhancing the quality of life for pseudomyxoma peritonei and appendix cancer patients.

In summary, our medical advisors provide tremendous value to Pseudomyxoma Survivor and our community through their medical expertise, research collaborations, education, advocacy, credibility and dedication to improving patient outcomes.

Meet the advisors

Dr Jason Spendelow

Dr Jason Spendelow

Supporting our commitment to living with pseudomyxoma peritonei and appendix cancer, we welcome Dr Spendelow as a medical advisor.

read more
Dr Aditi Bhatt

Dr Aditi Bhatt

Aditi Bhatt is an Indian surgical oncologist who specializes in the
management of primary peritoneal malignancies and secondary peritoneal metastases of gastrointestinal and gynecological origin.

read more
Dr Armando Sardi

Dr Armando Sardi

Dr. Sardi is one of Maryland’s leading surgical oncologists who use Hyperthermic Intraperitoneal Chemotherapy (HIPEC) to treat late stage, complex cancers of the abdominal region.

read more
Professor Norman Carr

Professor Norman Carr

Norman John Carr was previously Director of Research and Consultant Histopathologist at the Peritoneal Malignancy Institute, Basingstoke

read more
Laura Lambert MD

Laura Lambert MD

Laura Lambert, MD is a surgical oncologist who specializes in treating peritoneal surface malignancies including pseudomyxoma peritonei.

read more
Prof Wim P Ceelen

Prof Wim P Ceelen

Prof Wim Ceelen is a senior GI surgeon at Ghent University Hospital, also an Associate Professor in surgical oncology at Ghent University.

read more
Professor Paul Moroz

Professor Paul Moroz

Prof. Moroz advises Pseudomyxoma Survivor, as a specialist in pseudomyxoma peritonei and HIPEC treatment, based in Australia.

read more
Mr Omer Aziz

Mr Omer Aziz

Omer Aziz is a UK-based consultant colorectal surgeon at The Christie and a member of the Pseudomyxoma Survivor medical advisory board.

read more

About Pseudomyxoma Survivor

Our trustees, our patron and more.

Get in touch

You can email us, phone us or fill in the contact form.